According to the details of an American court case, pharmaceutical company Astrazeneca may have tried to bury adverse medical studies surrounding its high-selling drug Seroquel.
Seroquel has hit serious controversy, as it is alleged to give patients with psychiatric disorders diabetes . A class-action lawsuit has been filed in Florida, and Astrazeneca are being accused of a cover up.
According to the allegations, the company covered up a number of studies and suppressed data, including reports that two cheaper, generic equivalents were more effective than seroquel.
Even more seriously, it appears that documents reveal that the company knew that the drug caused diabetes and weight issues. A company doctor reportedly wrote: “there is reasonable evidence to suggest that Seroquel therapy can cause impaired glucose regulation including diabetes mellitus in certain individuals.”
Astrazeneca deny the charges.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…